{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:52:17Z","timestamp":1793407937667,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA233878-01"],"award-info":[{"award-number":["R01CA233878-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jvir.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T23:20:39Z","timestamp":1731280839000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0092-249X","authenticated-orcid":false,"given":"Andrew C.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-2270","authenticated-orcid":false,"given":"Rohan","family":"Savoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetal M.","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Kalyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5485-7227","authenticated-orcid":false,"suffix":"III","given":"Al B.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Hohlastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-8531","authenticated-orcid":false,"given":"Kush R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-788X","authenticated-orcid":false,"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2024.11.003_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.21037\/hbsn.2020.04.02","article-title":"Neuroendocrine liver metastases: a contemporary review of treatment strategies","volume":"9","author":"Cloyd","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jvir.2024.11.003_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A\u00a05-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2024.11.003_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2024.11.003_bib4","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1097\/RLU.0000000000001383","article-title":"Prospective longitudinal quality of life assessment in patients with neuroendocrine tumor liver metastases treated with 90y radioembolization","volume":"41","author":"Cramer","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jvir.2024.11.003_bib5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/SLA.0b013e3181728a45","article-title":"90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience","volume":"247","author":"Rhee","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2024.11.003_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjsurg.2003.04.007","article-title":"Management of neuroendocrine liver metastases","volume":"187","author":"Sutcliffe","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.jvir.2024.11.003_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.21037\/jgo.2016.02.02","article-title":"Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience","volume":"7","author":"Singla","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2024.11.003_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.suronc.2012.07.001","article-title":"Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review","volume":"21","author":"Yang","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jvir.2024.11.003_bib9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/SLA.0b013e3181d3d24a","article-title":"Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases","volume":"251","author":"Saxena","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2024.11.003_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00330-008-1211-7","article-title":"Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis","volume":"19","author":"Vente","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","article-title":"Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization","volume":"79","author":"Riaz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2024.11.003_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jvir.2017.08.026","article-title":"Radiation segmentectomy versus selective chemoembolization in the treatment of early-stage hepatocellular carcinoma","volume":"29","author":"Biederman","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jvir.2017.02.018","article-title":"Segmental yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study","volume":"28","author":"Padia","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2024.11.003_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jso.26223","article-title":"Yttrium-90 radiation segmentectomy for hepatic metastases: a multi-institutional study of safety and efficacy","volume":"123","author":"Padia","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jvir.2024.11.003_bib16","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1007\/s00261-021-02956-6","article-title":"Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres","volume":"46","author":"Kurilova","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jvir.2024.11.003_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.21037\/jgo.2017.11.02","article-title":"Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases","volume":"9","author":"Meiers","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2024.11.003_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jvir.2022.12.021","article-title":"Yttrium-90 radiation segmentectomy in oligometastatic secondary hepatic malignancies","volume":"34","author":"Chiu","year":"2023","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib19","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2010.262","article-title":"Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma","volume":"303","author":"Riaz","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jvir.2024.11.003_bib20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2967\/jnumed.121.263041","article-title":"Radioembolization versus bland or chemoembolization for liver-dominant neuroendocrine tumors: is it an either\/or question?","volume":"62","author":"Strosberg","year":"2021","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jvir.2024.11.003_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00270-016-1478-z","article-title":"Embolotherapy for neuroendocrine tumor liver metastases: prognostic factors for hepatic progression-free survival and overall survival","volume":"40","author":"Chen","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2214\/AJR.11.7066","article-title":"Chemoembolization practice patterns and technical methods among interventional radiologists: results of an online survey","volume":"198","author":"Gaba","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2024.11.003_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1148\/radiol.2018170962","article-title":"90Y radioembolization for hepatic malignancy in patients with previous biliary intervention: multicenter analysis of hepatobiliary infections","volume":"288","author":"Devulapalli","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2024.11.003_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1051-0443(07)61577-2","article-title":"Risk factors for liver abscess formation after hepatic chemoembolization","volume":"12","author":"Kim","year":"2001","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib25","article-title":"Radioembolization is a safe and effective treatment for hepatocellular carcinoma with portal vein thrombosis: a propensity score analysis","volume":"11","author":"Cho","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2024.11.003_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcell.2020.00041","article-title":"Molecular mechanisms of radiation-induced cancer cell death: a primer","volume":"8","author":"Sia","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jvir.2024.11.003_bib27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jvir.2018.02.002","article-title":"Long-term toxicity after transarterial radioembolization with yttrium-90 using resin microspheres for neuroendocrine tumor liver metastases","volume":"29","author":"Tomozawa","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jvir.2017.05.011","article-title":"Long-term hepatotoxicity of yttrium-90 radioembolization as treatment of metastatic neuroendocrine tumor to the liver","volume":"28","author":"Su","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.11.003_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/hepr.13446","article-title":"Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma","volume":"50","author":"Maesaka","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jvir.2024.11.003_bib30","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1002\/cam4.6464","article-title":"Transcatheter arterial embolization in patients with neuroendocrine neoplasms related to liver metastasis with different blood supplies","volume":"12","author":"Bai","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jvir.2024.11.003_bib31","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2024.11.003_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2024.11.003_bib33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jvir.2014.12.009","article-title":"Radiofrequency ablation for neuroendocrine liver metastases: a systematic review","volume":"26","author":"Mohan","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324006997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324006997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:12:44Z","timestamp":1737544364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324006997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1051044324006997"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2024.11.003","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2024","name":"copyright","label":"Copyright"}]}}